
Biology-powered production of renewable chemicals.
Capra Biosciences uses patented bioreactor technology to produce high-performance, renewable bio-based chemicals affordably and sustainably. The company is revolutionizing chemical production by transforming byproducts into valuable materials, with applications in pharmaceutical ingredient manufacturing and industrial chemicals. Capra has received a $7.5M DARPA project agreement to scale its platform.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.